Dual impact: CD38 inhibition in glycolysis and oxidative phosphorylation
J Leukoc Biol
.
2024 Sep 2;116(3):437-439.
doi: 10.1093/jleuko/qiae131.
Authors
Kathleen Klinzing
1
,
Satyajit Das
1
,
Paramita Chakraborty
1
Affiliation
1
Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas Street, Charleston, SC 29425, United States.
PMID:
38856163
DOI:
10.1093/jleuko/qiae131
No abstract available
Keywords:
CD38; HIV; T cells; metabolism.
Publication types
Editorial
MeSH terms
ADP-ribosyl Cyclase 1* / antagonists & inhibitors
ADP-ribosyl Cyclase 1* / metabolism
Animals
Glycolysis* / drug effects
Humans
Oxidative Phosphorylation* / drug effects
Substances
ADP-ribosyl Cyclase 1
Grants and funding
R01 CA250458/GF/NIH HHS/United States
Hollings Cancer Center
P30 CA138313/CA/NCI NIH HHS/United States
MUSC